Gambia vs Trinidad and Tobago: HPV immunization coverage estimates among primary target cohort (9-14)
Gambia
33.0%
in 2025
Trinidad and Tobago
41.0%
in 2025
Gambia rank
103rd
Trinidad and Tobago rank
100th
HPV immunization coverage estimates among primary target cohort (9-14) over time
- Gambia
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 41.0% against 33.0% in Gambia, a difference of 8.0%.
That makes Trinidad and Tobago's figure about 1.2 times Gambia's.
The two have swapped places 1 time across 5 shared years of data; in 2019 it was Gambia ahead.
Gambia ranks 103rd and Trinidad and Tobago ranks 100th of 111 countries.
Across the 2 decades both report, Gambia averaged higher in 1 and Trinidad and Tobago in 1.
Head to head by decade
| Decade | Gambia | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 64.0% | 17.0% | 47.0% | Gambia |
| 2020s | 26.0% | 32.8% | 6.8% | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hpv immunization coverage estimates among primary target cohort (9-14), Gambia or Trinidad and Tobago?
- Trinidad and Tobago, at 41.0% against 33.0% in Gambia as of 2025.
- What is the difference in hpv immunization coverage estimates among primary target cohort (9-14) between Gambia and Trinidad and Tobago?
- 8.0%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Gambia and Trinidad and Tobago?
- 5 years are reported by both, from 2019 to 2025.
- How do Gambia and Trinidad and Tobago rank globally for hpv immunization coverage estimates among primary target cohort (9-14)?
- Gambia ranks 103rd and Trinidad and Tobago ranks 100th of 111 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.